Stocksigma LogoStocksigma Logo

Max Healthcare Q2 FY27 Results: Gross Revenue Rises 20% YoY to ₹3,219 Cr

Max Healthcare reported Q2 FY27 network gross revenue of ₹3,219 Cr, up 20% YoY (+8% QoQ), with operating EBITDA rising 18% YoY to ₹820 Cr (26.8% margin)

Max Healthcare Q2 FY27 Results: Gross Revenue Rises 20% YoY to ₹3,219 Cr

Max Healthcare Institute Ltd · Investor Presentation · 30 Oct 2026, 8:24 pm

Max Healthcare Q2 FY27 Results: Gross Revenue Rises 20% YoY to ₹3,219 Cr Max Healthcare reported Q2 FY27 network gross revenue of ₹3,219 Cr, up 20% YoY (+8% QoQ), with operating EBITDA rising 18% YoY to ₹820 Cr (26.8% margin) and PAT growing 10% YoY to ₹448 Cr. Operational bed capacity reached 5,518 (+16% YoY) with 77% occupancy and an 8% increase in ARPP to ₹2.31 lakh. International patient revenue surged 33% YoY to ₹307 Cr. The board approved ₹415 Cr in capex for 209 brownfield beds across existing facilities, while net debt stood at ₹2,369 Cr as of 30th Sep'26.

Original exchange filing (PDF)

More announcements from Max Healthcare Institute Ltd

All Max Healthcare Institute Ltd announcements